Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 240Rectal Neoplasms 93Colonic Neoplasms 91Pancreatic Neoplasms 86Stomach Neoplasms 68Neoplasm Metastasis 47Esophageal Neoplasms 41Neoplasms 36Small Cell Lung Carcinoma 29Lung Neoplasms 29Neuroblastoma 28Glioblastoma 28Glioma 27Brain Neoplasms 26Carcinoma, Non-Small-Cell Lung 22Adenocarcinoma Of Esophagus 20Gliosarcoma 19Breast Neoplasms 18Astrocytoma 18Esophageal Squamous Cell Carcinoma 17Central Nervous System Neoplasms 17Unspecified Adult Solid Tumor, Protocol Specific 16Oligodendroglioma 13Adenocarcinoma 13Rhabdomyosarcoma 10Gastrointestinal Neoplasms 10Biliary Tract Neoplasms 10Sarcoma 9Gallbladder Neoplasms 9Sarcoma, Ewing 8

Interventions

Radiotherapy 3Cisplatin 2tislelizumab 1pembrolizumab 1Tamoxifen 1TP protocol 1Spinal Puncture 1Radiosurgery 1Paclitaxel 1Oxaliplatin 1Irinotecan 1Gemcitabine 1Gadolinium 1Fluorouracil 1Ethiodized Oil 1Cetuximab 1Carboplatin 1Blood Specimen Collection 1Anesthesia, General 1Androgen Antagonists 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Neoplasm Recurrence, Local × Irinotecan × Clear all
NCT02087475 2019-06-05

Perioperative FOLFIRI VS Adjuvant FOLFIRI in Resectable Advanced CRC Failed to Oxaliplatin

Sixth Affiliated Hospital, Sun Yat-sen University

Phase 3 Unknown
360 enrolled
Gastrointestinal

Neoplasm Metastasis, Neoplasm Recurrence, Local, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡